AAD 2023: Baricitinib Shows Long-Term Efficacy for Severe Alopecia
Further, efficacy increased between weeks 52 and 104 for patients with initial mixed response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.